INTERCEPT PHARMACEUTICALS IN

CUSIP: 45845PAB4 Class: CONV BD US

GABELLI FUNDS LLC's Holding History (CIK: 0001081407)

Note: Option positions (PUT/CALL) are excluded.

Q3 2020
Shares 3,300,000 Value ($000) $2,287 Avg Close — Range —
Q2 2020
Shares 3,300,000 Value ($000) $2,377 Avg Close — Range —
Q1 2020
Shares 3,300,000 Value ($000) $2,868 Avg Close — Range —
Q4 2019
Shares 3,300,000 Value ($000) $4,382 Avg Close — Range —
Q3 2019
Shares 3,300,000 Value ($000) $2,994 Avg Close — Range —